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Summary
Objectives To evaluate the quality of referrals to a neovascular age-
related macular degeneration clinic from optometrists using the standard
Rapid Access Referral Form (RARF) from the Royal College of
Ophthalmologists.
Design A prospective study. Prospective data were gathered from all
optometry referrals using the RARF, between the periods of December
2006 to August 2009. These were assessed for accuracy of history, clinical
signs and ﬁnal diagnosis as compared to a macula expert.
Setting Highlands NHS Trust.
Participants All patients referred to the eye department at NHS
Highlands Trust using the RARF.
Main outcome measures The symptoms of neovascular age-
related macular degeneration correctly identiﬁed by optometrists, and the
signs of neovascularage-related macular degeneration correctly identiﬁed
by optometrists.
Results Fifty-four RARFs were received during this period, therewas an
overall agreement with symptomatology in 57.4% of cases. Optometrists
scored less well in recognizing the clinical signs of neovascular age-
related macular degeneration, with the poorest scores for recognizing
macular oedema (44.4%) and drusen (51.9%). Twenty (37%) patients
referred had neovascular age-related macular degeneration.
Conclusions RARFs make up the minority of referrals to the
neovascular age-related macular degeneration clinic. Optometrists ﬁnd it
difﬁcult to accurately elicit the signs of macula disease.
Introduction
Neovascularage-related maculardegeneration is a
common cause of visual disability in the Western
world. Correct diagnosis and early treatment is
necessary to improve visual outcomes. In the
UK, specialist clinics have been set up to allow
quick referral and management. The UK govern-
ment has published national patient pathways
recommending that ﬁltering of patients with sus-
pected neovascular age-related macular degener-
ation, either self-referred or from general
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RESEARCH
1practitioners (GPs), takes place in the community
by qualiﬁed optometrists.
1 To assist in this, the
Royal College of Ophthalmologists have devel-
oped a Rapid Access Referral Form (RARF)
2
which can be used to refer patients with neovascu-
lar age-related macular degeneration directly to
the macula specialist.
In our study we assess the use and quality of
these referrals over a 21-month period to our
department in the NHS Highlands. The depart-
ment serves a large geographic area, with a popu-
lation of approximately 250,000. It is a specialist
centre for the diagnosis and treatment of wet
age-related macular degneration. There is a dedi-
cated age-related macular degneration clinic with
specialist facilities and a dedicated ophthalmolo-
gist specializing in macular disease.
Method
All optometrists taking part in the study had pre-
viously attended an educational meeting on neo-
vascular macular degeneration, as well as an
explanation on how to ﬁll in the RARF. This was
conducted by a consultant ophthalmologist with
a specialist interest in macula disease. In addition
they were made aware of the Royal College of
Ophthalmologists website with illustrated images
of neovascular age-related macular degeneration.
We conducted a prospective study of all opto-
metry referrals using the RARF, sent to our depart-
ment between the periods of December 2006 to
August 2009. These forms were analysed for
recorded history, clinical signs and the ﬁnal diag-
nosis. We compared these to the history ﬁndings,
clinical signs and diagnosis recorded by the con-
sultant ophthalmologist with a special interest in
macula disease.
The speciﬁc points recorded in the history
were:
1. Reduction of vision;
2. Distortion;
3. Central scotoma.
The clinical signs assessed were:
1. Haemorrhage;
2. Exudates;
3. Drusen;
4. Subretinal ﬂuid/macular oedema.
All patients were seen within two weeks of receipt
of the referral. The optometrist history was taken
from the RARF, and this was compared with the
history obtained by the ophthalmologist on the
same three points. As part of the initial examin-
ation a careful note was made as to whether any
of the clinical signs above were present or absent.
Results
During the period of study, 54 RARFs were
received and analysed as above.
The overall agreement between the specialist
and optometrist on all three history ﬁndings was
57.4%; optometrists scored well on reduction in
vision (85.2%) and distortion (88.9%), but
appeared less able to elicit symptoms of central
scotoma (61.1%). Optometrists scored less well
on correlation with clinical signs (Figure 1), haem-
orrhage (83.3%), exudates (66.7%), drusen (51.9%)
and subretinal ﬂuid (44.4%).
The total number of patients with a correct
diagnosis of neovascular age-related macular
degeneration was 20 (37%), with the other diag-
noses shown in Table 1.
Discussion
The principal ﬁndings of our study show that
optometrists perform satisfactorily in identifying
the symptoms of neovascular age-related
macular degeneration, but perform less well in
recognizing its clinical signs.
To our knowledge this study is the ﬁrst to
assess the quality of referrals to a neovascular
age-related macular degeneration clinic using the
fast track RARF in a prospective study. It shows
a low level of accuracy which results in a high pro-
portion of patients who do not have neovascular
age-related macular degeneration (63%) being
seen unnecessarily at the macula clinic. Optome-
trists may lack conﬁdence in recognizing the clini-
cal signs and diagnosing neovascular age-related
macular degeneration, and this may be why the
RARF is not used as commonly as it should.
Patients are instead referred to eye casualty and
general ophthalmology clinics for further assess-
ment and diagnosis. The total of 54 RARFs over
J R Soc Med Sh Rep 2011;2:64. DOI 10.1258/shorts.2011.011042
Journal of the Royal Society of Medicine Short Reports
2a 21-month period appears to represent a small
yield. During the same period 220 new patients
with a deﬁnite diagnosis of neovascular age-
related macular degeneration were enrolled in the
macula clinic. Many of these new patients came
via the eye casualty and other ophthalmologists’
clinics as well as GP referrals. It is difﬁcult to
know what exact proportion these 54 referrals con-
stitute of all neovascular age-related macular
degeneration referrals, as many patients would
have been seen by the other ophthalmologists
and where no neovascular age-related macular
degeneration was found then they would have
been managed appropriately or discharged.
However it would be reasonable given the
number of new patients enrolled, to assume that
this is a low percentage. Optometrists are reason-
ably accurate at eliciting symptoms from patients,
but had the poorest score for ‘central scotoma’. It
may be that further training would improve this.
In contrast, there was poor recognition of the clini-
cal signs of neovascular age-related macular
degeneration. Particular difﬁculty was observed
in recognizing subretinal ﬂuid/macular oedema
and drusen; the latter were commonly confused
for exudates. In recognizing haemorrhage, which
received a high score, it would be expected that
the remaining discrepancy was because haemor-
rhage had developed in the two weeks prior to
being seen in clinic. However in eight out of
nine cases of disagreement, the specialist found
no haemorrhage on examining the macula.
There have been studies which show that opto-
metrists are good at screening for conditions such
as glaucoma. Blanco et al.
5 selected optometrists
after a written exam and then trained them in
glaucoma clinics until both parties were satisﬁed
of their clinical skills. They achieved good results
for accurate diagnosis and decision to treat, com-
parable to junior trainees. Other studies appear
to contradict this showing a high level of inaccur-
acy in diagnosis and incomplete assessment on
referral forms.
6 It may be that certain optometrists
need to be selected with the correct aptitude, and
undergo a period of training in specialist centres
looking at one particular group of pathologies,
such as macular disease.
One method of possibly improving the accu-
racy of referrals would be to create a telemedicine
system with the ability to send referrals with pic-
tures and OCT scans. Cameron et al.
7 found such
a system to be useful in improving accuracy of
referrals; however in their study they looked at a
variety of conditions including cataract, glaucoma
Figure 1
A graph showing the percentage correct diagnosis of each clinical
sign by the optometrist
Table 1
Diagnosis frequency for all patients referred to
neovascular age-related macular degeneration
clinic
Diagnosis Patients (n, %)
Exudative AMD 20 (37.0)
Dry AMD 10 (18.5)
ERM 5 (9.3)
BRVO 4 (7.4)
CSR 4 (7.4)
Macular scar 3 (5.6)
PVD 2 (3.7)
Retinoschisis 1 (1.9)
Adult foveo-macular dystrophy 1 (1.9)
Macular hole 1 (1.9)
Vitreomacular traction 1 (1.9)
Glaucoma 1 (1.9)
Diabetic maculopathy 1 (1.9)
AMD= age-related macular degeneration; ERM =
epi-retinal membrane; BRVO=branch retinal vein
occlusion; CSR= central serous retinopathy;
PVD =posterior vitreous detachment
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3and diabetic retinopathy. Our region covers a
large geographic areawith a large numberof opto-
metrists, and this would represent a considerable
cost in order to equip all of their units and
provide training. In addition given the anticipated
number of referrals it would necessitate the
specialist ophthalmologist dedicating clinical
time to vet the referral letters and accompanying
images, before making the decisions as to
whether the patient needs to be seen in the
macula clinic or referred elsewhere.
It is necessary in this modern climate for there
to be reliable co-dependence between optome-
trists and ophthalmologists,
3 and optometrists
are expected to take on a ﬁltering role for con-
ditions including neovascular age-related
macular degeneration. In our study they
struggled to achieve accurate levels of sensitivity
(37%). Without knowing the number of patients
incorrectly diagnosed as having no neovascular
age-related macular degeneration, it is not poss-
ible to assess the speciﬁcity. However it would
appear that optometrists in our study have a
low threshold for referring any abnormality
and so the speciﬁcity may indeed be very low.
It is likely that the reason for this is that unrea-
sonable expectation is being placed on the opto-
metrist without adequate training. We expect
them to accurately take a history and recognize
clinical signs, in order to recognise neovascular
age-related macular degeneration distinguishing
it from othermacularconditions with similar fea-
tures and refer them straight to a macula clinic.
This can be very challenging to a group of
professionals who have not had regular training
in a hospital setting under the supervision of
specialist tutors. In our unit wewould not normally
expect our trainees to adequately do this task unsu-
pervised until many hours of supervised training.
H e n c eo p t o m e t r i s t sm a yn o tb eb e s ts u i t a b l et o
perform the screening role.
4
There has been much debate regarding the role of
the optometrist in screening for neovascular age-
related macular degeneration.
8,9 It is likely that opto-
metrists can further improve their diagnostic skills
with the correct aptitude and training in specialist
units. However this does represent a signiﬁcant
commitment in terms of time and cost on the part
of the specialist unit/trainer and the optometrist.
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